GSK's consumer health spinout Haleon started trading on the London Stock Exchange this morning, making its debut with a price of 330 pence and a market valuation of around £31 billion ($37 billion).

With the launch of Polident, which is the global market leader in the denture care, the company has reinforced its presence in the overall oral health category in India, GSK Consumer Healthcare ...

For GSK CEO Emma Walmsley, there was good news and bad news in the company’s annual report. | For GSK CEO Emma Walmsley, ...

ViiV Healthcare's EMBRACE study shows VH109 with CAB LA effectively suppresses HIV. The company also reports promising early ...

GSK), formerly known as GlaxoSmithKline, is a global pharmaceutical and healthcare corporation based in the United Kingdom that creates and distributes a variety of medications, vaccines, and consumer ...

GSK Plc is a healthcare company, which engages in the research, development, and manufacture of pharmaceutical medicines, vaccines, and consumer healthcare products. It operates through the ...

Discover GSK's impressive stock surge, boosted by strong earnings, a share buyback program, and a focus on specialty medicines.

In this article, we are going to take a look at where GSK plc (NYSE:GSK ... On February 21, Jared Holz, Mizuho Securities America’s healthcare sector strategist, appeared on CNBC to talk ...